arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Bolt Biotherapeutics, Inc.

BOLT Health Care Biotechnology: Pharmaceutical Preparations
$4.19
▼ -2.8% Today
as of Oct 22, 16:46 ET
Last 30 days +5.28% Sep 14 → Oct 22
$3.27 $3.55 $3.83 $4.11 $4.39 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$4.13
High
$4.21
Low
$4.06
Volume
$14,053
Avg Vol
$30,025
Mkt Cap
$7M
P/E (TTM)
—
Beta
—
52w High
$7.20
52w Low
$3.10
Div Yield
—
Shares Out
$2M

BOLT earnings at a glance

Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±2.5% on average; after the most recent report on May 12, 2026 it moved +1.7%. BOLT beat the consensus EPS estimate in 3 of its last 4 reported quarters. The share price of $4.19 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.10
$7.20
27% of range
Avg surprise (last 4)
+5.1%
Avg reaction (last 2)
+2.5%
100% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-11.12$-8.41$-5.70$-2.99$-0.28 Actual $-0.45Actual $-0.48Actual $-0.43Actual $-0.28Actual $-11.12Actual $-7.93Actual $-0.29Est $-0.34Actual $-4.46Est $-6.40Actual $-3.72Est $-5.07Actual $-4.31Est $-2.85Actual $-4.57 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-15M$-11M$-6M$-2M$2M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-4.57 — — — — financials
Tue May 12, 2026Mar/2026 $-4.31 $-2.85 -51.2% -1,386% +1.7% earnings
Wed Nov 12, 2025Sep/2025 $-3.72 $-5.07 +26.6% — — earnings
Thu Aug 14, 2025Jun/2025 $-4.46 $-6.40 +30.3% — — earnings
Mon May 12, 2025Mar/2025 $-0.29 $-0.34 +14.7% — +3.4% earnings
Mon Sep 30, 2024Sep 2024 $-7.93 — — — — financials
Sun Jun 30, 2024Jun 2024 $-11.12 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.28 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.43 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.48 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.45 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$5,000$26,000—$2M$2M$1M—$1M
Cost of revenue————————
Gross profit————————
Operating income$-8M$-8M—$-8M$-9M$-12M—$-16M
Net income$-8M$-7M—$-7M$-9M$-11M—$-15M
EPS (diluted)$-4.57$-4.31—$-3.72$-4.46$-5.76—$-7.93

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$13M$12M$12M$18M$10M$8M$7M$9M
Inventory————————
Total current assets$21M$26M$30M$36M$38M$43M$51M$57M
Total assets$40M$48M$57M$65M$75M$86M$100M$109M
Long-term debt————————
Total liabilities$28M$28M$30M$33M$37M$39M$42M$37M
Total equity$13M$20M$27M$32M$39M$47M$57M$72M

Implied volatility — last 90 days

No IV snapshots yet for BOLT.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

BOLT earnings FAQ

How does BOLT stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.5%, up 2 times and down 0 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.